JP2015502356A - ５−ｆｕに関連するアッセイ、抗体、免疫原および組成物 - Google Patents

５−ｆｕに関連するアッセイ、抗体、免疫原および組成物 Download PDF

Info

Publication number
JP2015502356A
JP2015502356A JP2014544935A JP2014544935A JP2015502356A JP 2015502356 A JP2015502356 A JP 2015502356A JP 2014544935 A JP2014544935 A JP 2014544935A JP 2014544935 A JP2014544935 A JP 2014544935A JP 2015502356 A JP2015502356 A JP 2015502356A
Authority
JP
Japan
Prior art keywords
antibody
sample
reactivity
assay
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014544935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015502356A5 (https=
Inventor
ポール キュー． フー，
ポール キュー． フー，
シャオフェン フアン，
シャオフェン フアン，
ボルステル， リード ダブリュー． ボン
ボルステル， リード ダブリュー． ボン
Original Assignee
ウェルスタット ダイアグノスティクス，エルエルシー
ウェルスタット ダイアグノスティクス，エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ウェルスタット ダイアグノスティクス，エルエルシー, ウェルスタット ダイアグノスティクス，エルエルシー filed Critical ウェルスタット ダイアグノスティクス，エルエルシー
Publication of JP2015502356A publication Critical patent/JP2015502356A/ja
Publication of JP2015502356A5 publication Critical patent/JP2015502356A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00—Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
JP2014544935A 2011-11-30 2012-11-30 ５−ｆｕに関連するアッセイ、抗体、免疫原および組成物 Pending JP2015502356A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161565281P 2011-11-30 2011-11-30
US61/565,281 2011-11-30
US201261665686P 2012-06-28 2012-06-28
US61/665,686 2012-06-28
PCT/US2012/067353 WO2013082463A2 (en) 2011-11-30 2012-11-30 Assays, antibodies, immunogens and compositions related to 5-fu

Publications (2)

Publication Number Publication Date
JP2015502356A true JP2015502356A (ja) 2015-01-22
JP2015502356A5 JP2015502356A5 (https=) 2016-01-21

Family

ID=48536238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014544935A Pending JP2015502356A (ja) 2011-11-30 2012-11-30 ５−ｆｕに関連するアッセイ、抗体、免疫原および組成物

Country Status (6)

Country Link
US (1) US9702869B2 (https=)
EP (1) EP2785736A4 (https=)
JP (1) JP2015502356A (https=)
AU (1) AU2012327223A1 (https=)
CA (1) CA2857645A1 (https=)
WO (1) WO2013082463A2 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018104398A (ja) * 2016-12-28 2018-07-05 Jsr株式会社 磁性粒子分散液
JP2019506390A (ja) * 2016-01-21 2019-03-07 ザ スクリプス リサーチ インスティテュート 合成オピオイドワクチン
JP2019132675A (ja) * 2018-01-31 2019-08-08 国立研究開発法人産業技術総合研究所 標的物質検出方法及び導波モードセンサ
JP2023127206A (ja) * 2022-03-01 2023-09-13 学校法人早稲田大学 小型非荷電分子の検出方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10401368B2 (en) 2014-03-20 2019-09-03 Pdl Biopharma, Inc. Antibodies and methods for the detection of cell death
CN111875587B (zh) * 2020-07-23 2021-07-13 湖南苏阳医疗科技有限公司 5-氟胞嘧啶衍生物、其制备方法及其在5-氟胞嘧啶免疫检测试剂中的应用
WO2022119937A1 (en) * 2020-12-03 2022-06-09 Ortho-Clinical Diagnostics, Inc. Lithium heparin as a blocking agent
CN113501877A (zh) * 2021-08-23 2021-10-15 苏州科铭生物技术有限公司 抗5-氟尿嘧啶单克隆抗体的制备方法、5-氟尿嘧啶的酶联免疫检测方法
CN114487059B (zh) * 2021-12-29 2022-11-25 苏州大学 一种电化学发光免疫传感器及其制备和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177884A1 (en) * 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
CN101461948A (zh) * 2009-01-04 2009-06-24 广东药学院 一种叶酸介导的5-氟尿嘧啶白蛋白大分子前体药物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366862A (en) * 1990-02-14 1994-11-22 Receptor Laboratories, Inc. Method for generating and screening useful peptides
US20030017147A1 (en) 1996-09-20 2003-01-23 Guy L Reed Composition and method for enhancing fibrinolysis
DE10020376A1 (de) * 2000-04-26 2001-11-08 Inst Zelltechnologie E V Dynamische Marker
WO2006044643A2 (en) * 2004-10-15 2006-04-27 Seattle Genetics, Inc. Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
AU2008330125B2 (en) * 2007-11-21 2012-11-22 Amgen Inc. Wise binding antibodies and epitopes
AU2010222942B2 (en) 2009-03-10 2013-01-10 Baylor Research Institute Anti-CD40 antibodies and uses thereof
CN102770457A (zh) * 2009-03-10 2012-11-07 贝勒研究院 靶向抗原呈递细胞的疫苗
CA2685842A1 (en) * 2009-07-16 2011-01-16 University College Cork, National University Of Ireland, Cork A method for the treatment of cancer
CA2768488A1 (en) 2009-07-17 2011-01-20 Myriad Genetics, Inc. Method of assaying 5-fu
ES2724975T3 (es) * 2009-12-10 2019-09-18 Regeneron Pharma Ratones que producen anticuerpos de cadena pesada

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177884A1 (en) * 2005-02-08 2006-08-10 Saladax Biomedical Inc. 5-Fluoro-uracil immunoassay
JP2008530528A (ja) * 2005-02-08 2008-08-07 サラダックス バイオメディカル インク． ５−フルオロ−ウラシル免疫測定法
CN101461948A (zh) * 2009-01-04 2009-06-24 广东药学院 一种叶酸介导的5-氟尿嘧啶白蛋白大分子前体药物及其制备方法和应用

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019506390A (ja) * 2016-01-21 2019-03-07 ザ スクリプス リサーチ インスティテュート 合成オピオイドワクチン
JP2018104398A (ja) * 2016-12-28 2018-07-05 Jsr株式会社 磁性粒子分散液
WO2018124185A1 (ja) * 2016-12-28 2018-07-05 Jsr株式会社 磁性粒子分散液
US11320430B2 (en) 2016-12-28 2022-05-03 Jsr Corporation Magnetic particle dispersion
JP2019132675A (ja) * 2018-01-31 2019-08-08 国立研究開発法人産業技術総合研究所 標的物質検出方法及び導波モードセンサ
JP7104911B2 (ja) 2018-01-31 2022-07-22 国立研究開発法人産業技術総合研究所 標的物質検出方法及び導波モードセンサ
JP2023127206A (ja) * 2022-03-01 2023-09-13 学校法人早稲田大学 小型非荷電分子の検出方法
JP7709140B2 (ja) 2022-03-01 2025-07-16 学校法人早稲田大学 小型非荷電分子の検出方法

Also Published As

Publication number Publication date
EP2785736A2 (en) 2014-10-08
EP2785736A4 (en) 2015-12-09
AU2012327223A1 (en) 2013-06-20
CA2857645A1 (en) 2013-06-06
US20150079612A1 (en) 2015-03-19
US9702869B2 (en) 2017-07-11
WO2013082463A3 (en) 2013-08-15
WO2013082463A2 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
US9702869B2 (en) Assays, antibodies, immunogens and compositions related to 5-FU
JP6948415B2 (ja) 抗ｇｐ７３モノクローナル抗体およびそれを得る方法
JP5730200B2 (ja) 抗ヘプシジン−２５選択的抗体およびその使用
JP2022166172A (ja) 抗ｐｄ－ｌ１抗体
ES2973217T3 (es) Anticuerpos monoclonales contra la progastrina y sus utilizaciones
JP7363007B2 (ja) 食道癌の検出および治療のための組成物および方法
JP5545814B2 (ja) 抗体依存性細胞障害活性を模擬する抗体の結合活性測定法
JP2016501881A (ja) 血液脳関門（ｂｂｂ）を透過する二重特異性結合タンパク質
CN111094352A (zh) B7-h4抗体及其使用方法
TW201909926A (zh) Ｂ７ｈ３抗體－藥物偶聯物及其醫藥用途
JP7279761B2 (ja) 卵巣癌の検出および治療のための組成物および方法
JP7478708B2 (ja) 胃癌の検出および治療のための組成物および方法
JP2015527987A (ja) 薬物モニタリングのための抗トファシチニブ抗体およびその使用
KR20240040097A (ko) Cd3 표적화 항체 및 이의 용도
JP2025508753A (ja) 成長ホルモン受容体標的化ポリペプチド
CA3099968A1 (en) Use for preventing and treating myeloid-derived suppressor cell-related diseases
JP2021515210A (ja) 免疫療法のためのバイオマーカーとしてのプロガストリン
CN113135994B (zh) 一种激活型抗ox40抗体、生产方法及应用
JP2024508222A (ja) 抗Ｍｃｌ１抗体を投与することによる癌を監視するための材料及び方法
WO2025201513A1 (zh) 抗il1rap抗体及其用途
CN119818701A (zh) 抗体药物偶联物及其医药用途
CN113135994A (zh) 一种激活型抗ox40抗体、生产方法及应用
EA050277B1 (ru) Способ диагностики in vitro рака пищевода и способ мониторинга эффективности его лечения
EA050244B1 (ru) Способ диагностики in vitro рака желудка и способ мониторинга эффективности его лечения
EA050261B1 (ru) Способ in vitro диагностики рака яичников и способ мониторинга эффективности его лечения

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151127

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160916

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170414